Exceptional high number of IPD cases in winter season 2024–2025 in Belgium in concomitance with rise in vaccine serotypes

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2025-09-17 DOI:10.1016/j.vaccine.2025.127763

Lize Cuypers , Cato Dambre , Stefanie Desmet

引用次数: 0

Abstract

Following lifting of containment measures post-COVID, the number of invasive pneumococcal disease (IPD) infections continued to increase, reaching a record number last winter season 2024–2025 in Belgium. This exceptional increase is largely due to high numbers in (older) adults, and mainly an increase of vaccine serotype IPD. Over 95 % of IPD cases last winter could theoretically be prevented by vaccination. Cases of serotypes 12F, 14 and 4 were three or more times higher compared to pre-COVID winter season 2019–2020.

查看原文本刊更多论文

比利时2024-2025年冬季IPD病例数量异常高，同时疫苗血清型增加。

随着疫情防控措施的解除，侵袭性肺炎球菌病（IPD）感染人数继续增加，比利时在去年冬季（2024-2025年）达到创纪录的数字。这一异常增长主要是由于（老年人）成人人数较多，主要是疫苗血清型IPD的增加。去年冬天95%以上的IPD病例理论上可以通过接种疫苗来预防。与2019-2020年冬季covid前相比，血清型12F、14和4的病例增加了三倍或更多。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.